CARE TRANSFORMATION COLLABORATIVE OF RI

EIN: 472304987 501(c)(3) Health Care

WARWICK, RI

Total Revenue
$4,851,695
Total Expenses
$4,533,141
Total Assets
$6,486,832
Net Assets
$6,181,561
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2015
Legal Domicile
RI
Principal Officer
JOHN MINICHIELLO
Phone
6176209490
Tax Period
2024-07-01 to 2025-06-30

CARE TRANSFORMATION COLLABORATIVE OF RI, founded in 2015, is a community nonprofit in the Health Care sector that reported $4.9M in total revenue in fiscal year 2024. Expenses of $4.5M left a modest 7% surplus.

Mission

THE MISSION OF CTC-RI IS TO SUPPORT THE CONTINUING TRANSFORMATION OF PRIMARY CARE IN RHODE ISLAND AS THE FOUNDATION OF AN EVER-IMPROVING INTEGRATED, ACCESSIBLE, AFFORDABLE, AND EQUITABLE HEALTH CARE SYSTEM. CTC-RI BRINGS TOGETHER CRITICAL STAKEHOLDERS TO IMPLEMENT, EVALUATE AND SPREAD EFFECTIVE MULTI-PAYER MODELS TO DELIVER, PAY FOR AND SUSTAIN HIGH-QUALITY, COMPREHENSIVE, ACCOUNTABLE PRIMARY CARE.

Program Service Accomplishments

Program 1
Expenses: $4,054,465 Revenue: $1,386,090

RI ADULT IMMUNIZATION QUALITY IMPROVEMENT INITIATIVE:RI DEPARTMENT OF HEALTH CONTRACTED WITH THE CARE TRANSFORMATION COLLABORATIVE OF RHODE TO PROVIDE PROJECT MANAGEMENT AND QUALITY IMPROVEMENT...

Read more

RI ADULT IMMUNIZATION QUALITY IMPROVEMENT INITIATIVE:RI DEPARTMENT OF HEALTH CONTRACTED WITH THE CARE TRANSFORMATION COLLABORATIVE OF RHODE TO PROVIDE PROJECT MANAGEMENT AND QUALITY IMPROVEMENT SUPPORT FOR A NINE-MONTH QUALITY IMPROVEMENT INITIATIVE TO IMPROVE ADULT IMMUNIZATION RATES USING EVIDENCE-BASED TOOLS OF THE PRACTICE CHOOSING WITH THE SHARED GOALS OF A) ENSURING THAT NEARLY ALL PATIENTS WERE COUNSELED AND RECEIVE RECOMMENDED VACCINES AND B) TO UTILIZE AND PROVIDE FEEDBACK ON THE RHODE ISLAND CHILD AND ADULT IMMUNIZATION REGISTRY (RICAIR) WHICH HAD BEEN IMPLEMENTED DURING COVID (2020). POPULATIONS OF FOCUS INCLUDED PATIENTS WITH DIABETES THAT FACE A HIGHER RISK OF COMPLICATIONS FROM VACCINE-PREVENTABLE ILLNESSES INCLUDING COVID-19, INFLUENZA, PNEUMONIA AND INFECTIONS CAUSED BY DIPHTHERIA, TETANUS AND PERTUSSIS AND PREGNANT PEOPLE AND THEIR BABIES WHO ARE ESPECIALLY VULNERABLE TO COVID-19 AND INFLUENZA. PARTICIPATING PRACTICES INCLUDED SIX PRACTICE SITES THAT FOCUSED ON PATIENTS WITH DIABETES AND THREE PRACTICES THAT FOCUSED ON PRENATAL PATIENTS. OVER THE COURSE THE QUALITY IMPROVEMENT INITIATIVE, PRACTICES IDENTIFIED A QUALITY IMPROVEMENT TEAM, COMPLETED PRE AND POST BEST PRACTICES READINESS ASSESSMENT TOOLS, PROVIDED BASELINE, MID-POINT AND FINAL VACCINE PERFORMANCE RATES ON SELECTED VACCINES, MET MONTHLY WITH A PRACTICE FACILITATOR TO IDENTIFY AND IMPLEMENT PERFORMANCE IMPROVEMENT PLANS AND PRESENT FINDINGS INCLUDING CHALLENGES AND SUCCESSES AT THREE PEER LEARNING SESSIONS. PRACTICES IMPROVED THEIR PERFORMANCE WITH UTILIZING BEST PRACTICE STRATEGIES WITH GREATEST IMPROVEMENT NOTED IN KEEPING STAFF UP TO DATE ON CURRENT RECOMMENDATIONS, MAINTAINING COMPLETE UP-TO-DATE REGISTRIES, ASSESSING NEED FOR VACCINES AT EVERY VISIT, PROVIDING PATIENTS WITH ROUTINE REMINDERS, IDENTIFYING AN IMMUNIZATION CHAMPION AND EVALUATING AND IMPROVING PRACTICE PERFORMANCE. VACCINE PERFORMANCE RATES IMPROVED FOR ALL VACCINES. FOR PATIENTS WITH DIABETES: PERFORMANCE RATES FOR TD IMPROVED FROM BASELINE OF 56% TO 62%; PNEUMOCOCCAL IMPROVED FROM 52% TO 58%; INFLUENZA IMPROVED FROM 39% TO 52% AND COVID IMPROVED FROM 20% TO 26%. FOR PREGNANT PEOPLE: PERFORMANCE RATES FOR TD OR TDAP IMPROVED FROM BASELINE OF 73% TO 77% INFLUENZA IMPROVED FROM 56% TO 69% AND COVID IMPROVED FROM 0% TO 9% THIS QUALITY IMPROVEMENT INITIATIVE IS IMPORTANT BECAUSE IT DEMONSTRATED THAT EVEN WITH VACCINE HESITANCY AND RAMPANT MISINFORMATION, PRIMARY CARE PROVIDER RECOMMENDATIONS, IMPROVED PRACTICE WORKFLOWS AND PATIENT REMINDERS, TAILORING AND CUSTOMIZING PATIENT EDUCATION (INCLUDING OUTREACH TO FATHERS), OFFERING VACCINE CLINICS, MEASURING IMMUNIZATION PERFORMANCE RATES AND INVOLVING STAFF IN PERFORMANCE IMPROVEMENT EFFORTS RESULTS IN IMPROVED VACCINE PERFORMANCE THAT HAS SIGNIFICANT IMPACT ON KEEPING PATIENTS THAT ARE HIGHER RISK PROTECTED FROM PREVENTABLE ILLNESSES. TRAINING PEDIATRIC & FAMILY MEDICINE PROVIDERS TO DIAGNOSE AUTISM IN YOUNG CHILDRENTHE CARE TRANSFORMATION COLLABORATIVE OF RHODE ISLAND (CTC-RI), IN PARTNERSHIP WITH THE RHODE ISLAND DEPARTMENT OF HEALTH (RIDOH) AND WITH FUNDING FROM UNITEDHEALTHCARE, LAUNCHED A TRAINING INITIATIVE FOR PRIMARY CARE PROVIDERS TO IMPROVE TIMELY DIAGNOSIS OF AUTISM AND DEVELOPMENTAL DELAYS. THE PROGRAM ADDRESSES LONG WAIT TIMES FOR SPECIALTY EVALUATIONS, WHICH PARENTS OF CHILDREN WITH SPECIAL HEALTH CARE NEEDS IDENTIFIED AS A MAJOR BARRIER TO ACCESSING DIAGNOSTIC SERVICES. BY EQUIPPING PRIMARY CARE PROVIDERS TO DIAGNOSE CLEAR CASES, CHILDREN CAN BEGIN TAILORED INTERVENTIONS SOONER.FOLLOWING AN ENVIRONMENTAL SCAN, CTC-RI PARTNERED WITH VANDERBILT UNIVERSITY TO ADOPT ITS EVIDENCE-BASED ASD-PEDS ASSESSMENT AND TRAINING MODEL. THREE RHODE ISLAND-BASED CONSULTANTS WERE TRAINED TO SERVE AS TRAINERS AND RESOURCES FOR PROVIDERS, SUPPORTED BY A PRACTICE FACILITATOR FOR IMPLEMENTATION AND BILLING GUIDANCE. FIFTEEN PEDIATRIC PROVIDERS AND FOUR INTEGRATED BEHAVIORAL HEALTH CLINICIANS ENROLLED IN THE PROGRAM. TRAINING INCLUDED A TWO-DAY IN-PERSON SESSION, FOLLOWED BY VIRTUAL SESSIONS, A COMMUNITY OF PRACTICE, AND ONGOING IMPLEMENTATION SUPPORT WHICH WILL CONTINUE THROUGH DEC 2026.RIDOH PRIMARY CARE TRAINING SITES PROGRAMCTC-RI, IN PARTNERSHIP WITH RHODE ISLAND DEPARTMENT OF HEALTH OFFICE OF PRIMARY CARE AND RURAL HEALTH LAUNCHED THE RIDOH PRIMARY CARE PRIMARY CARE TRAINING SITES PROGRAM. THE PROGRAM, WHICH RECEIVED $2.7 M IN STATE FUNDING FOR ITS INAUGURAL YEAR, AIMS TO INCREASE THE CAPACITY FOR TRAINING STUDENTS IN PRIMARY CARE SETTINGS BY PROVIDING FUNDING TO PRIMARY CARE SITES THAT PRECEPT MEDICAL, NURSE PRACTITIONER AND PHYSICIAN ASSISTANT STUDENTS, MEDICAL RESIDENTS AND FELLOWS. CTC-RI CONVENED SUBJECT MATTER EXPERTS TO CREATE A CURRICULUM FOR THE PROGRAM THAT ENSURES TRAINEES LEARN ABOUT THE PATIENT-CENTERED MEDICAL HOME MODEL AND ADVANCED PRIMARY CARE PROVIDED AT THE TRAINING SITES. AS PART OF THE PROGRAM, CTC-RI HOSTS QUARTERLY COLLABORATIVE LEARNING SESSIONS AND MONTHLY DROP-IN SUPPORT FOR PRECEPTORS TO CREATE A COMMUNITY OF PRIMARY CARE PRECEPTORS AND PROVIDE EDUCATION ON TEACHING SKILLS, PROGRAM OPERATIONS AND OTHER TOPICS OF INTEREST. CURRENTLY THERE ARE 34 PATIENT-CENTERED MEDICAL HOME PRIMARY CARE SITES WITH OVER 130 PRECEPTORS ENROLLED IN THE PROGRAM REPRESENTING A 68% INCREASE IN CAPACITY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $3,318,114
Program Service Revenue $1,351,397
Investment Income $147,491
Other Revenue $34,693
TOTAL REVENUE $4,851,695

Expense Breakdown

Grants Paid $0
Salaries & Benefits $1,426,760
Fundraising Expenses $0
Program Expenses $4,054,465
Other Expenses $3,106,381
TOTAL EXPENSES $4,533,141

Year-over-Year Comparison

2024 2023 Change
Revenue $4,851,695 $4,572,220 +0.1%
Expenses $4,533,141 $4,536,475 0.0%
Net Income $318,554 $35,745 +7.9%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
27
Independent Members
21
Employees
13
Volunteers
24

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
8
$184,940
Total Directors
29
$13,101
Key Employees
0
$0
Highest Compensated
2
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
AL CHARBONNEAU MPS DIRECTOR 1.00
Director
$0 $0 $0
AMY NUNN MS SCD DIRECTOR 1.00
Director
$0 $0 $0
BARRY FABIUS MD DIRECTOR 1.00
Director
$0 $0 $0
CAROLINE RICHARDSON MD DIRECTOR 1.00
Director
$0 $0 $0
CATHLEEN NEWMAN MBA DIRECTOR (AS OF 3/25) 1.00
Director
$0 $0 $0
CHRISTOPHER OTTIANO MD DIRECTOR 1.00
Director
$0 $0 $0
COLLEEN VITALE MD FAAP DIRECTOR 1.00
Director
$0 $0 $0
CORY KING CO-CONVENER 1.00
Officer Director
$0 $0 $0
DEBORAH MASLAND DIRECTOR 1.00
Director
$0 $0 $0
DENISE COPPA PHD MS NP DIRECTOR 1.00
Director
$2,000 $0 $2,000
DOMENIC DELMONICO MBA DIRECTOR (TO 11/24) 1.00
Director
$0 $0 $0
ELIZABETH LANGE MD PRESIDENT (AS OF 10/24) 1.00
Officer Director
$5,501 $0 $5,501
EUGENIO FERNANDEZ JR PHARMD MBA M DIRECTOR 1.00
Director
$0 $0 $0
FARAH SHAFI MD DIRECTOR (TO 3/25) 1.00
Director
$0 $0 $0
HUGO YAMADA MD DIRECTOR 1.00
Director
$600 $0 $600
JEFFREY BORKAN MD DIRECTOR 1.00
Director
$2,000 $0 $2,000
KRISTIN SOUSA CO-CONVENER 1.00
Officer Director
$0 $0 $0
LARRY WARNER MPH SECRETARY 1.00
Officer Director
$0 $0 $0
LAURA STANTON MD DIRECTOR 1.00
Director
$0 $0 $0
MATTHEW HARVEY MPP DIRECTOR (TO 2/25) 1.00
Director
$0 $0 $0
MAUREEN MAIGRET RN BS MPA DIRECTOR 1.00
Director
$1,000 $0 $1,000
MICHELLE ANVAR MD DIRECTOR 1.00
Director
$0 $0 $0
NADINE HEWAMUDALIGE MD FAAFP DIRECTOR 1.00
Director
$0 $0 $0
NOAH BENEDICT MHL TREASURER 1.00
Officer Director
$2,000 $0 $2,000
PAUL LARSON MD MS MBA CPE DIMPH DIRECTOR 1.00
Director
$0 $0 $0
PETER HOLLMANN MD DIRECTOR (AS OF 10/24) 1.00
Officer Director
$0 $0 $0
RAJ HAZARIKA MD SM DIRECTOR 1.00
Director
$0 $0 $0
SARAH MANGIARELLI CPA DIRECTOR 1.00
Director
$0 $0 $0
THOMAS BLEDSOE MD DIRECTOR 1.00
Director
$0 $0 $0
DEBRA HURWITZ EXECUTIVE DIRECTOR (TO 2/25) 28.00
Officer
$170,333 $7,106 $177,439
JOHN MINICHIELLO EXECUTIVE DIRECTOR (AS OF 3/25) 32.00
Officer
$0 $0 $0
LINDA CABRAL SENIOR PROJECT MANAGER 40.00
Highest
$113,766 $29,587 $143,353
SUSANNE CAMPBELL SENIOR PROGRAM ADMINISTRAT 40.00
Highest
$144,298 $35,541 $179,839
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $4,851,695 $4,533,141 $6,486,832 $318,554
2024 No data No data No data No data
2023 $5,963,991 $4,770,357 $6,188,533 $1,193,634
2022 $6,655,544 $5,894,996 $5,109,176 $760,548
2021 $8,219,846 $6,559,479 $5,216,226 $1,660,367
2020 $7,068,039 $6,856,431 $3,504,530 $211,608
2019 $6,078,728 $5,724,923 $2,897,781 $353,805
2018 $5,474,078 $5,195,558 $2,654,944 $278,520
Explore More Nonprofits
Top 100 Nonprofits in Rhode Island Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare CARE TRANSFORMATION COLLABORATIVE OF RI with other nonprofits in Rhode Island and across the country.